For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
If incorrect, please enter your country/region into the box below, to view site information related to your country/region.
Don't have an account?
Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.
Create custom solutions with us
Partner with us
Access advice and support for any research roadblock
View support hub
Your experiments laid out step by step
Full event breakdown with abstracts, speakers, registration and more
View global event calendar
View all pathways
View all interactive pathways
Supporting our customers and employees during the COVID-19 pandemic. Read more
For optimal epitope retrieval to ensure superior staining in immunohistochemistry (IHC). Try our ready-to-use, optimized reagents.
Read the guide to our IHC detection substrates and chromogens to help you choose the right method for you.
Trying to achieve clean, sensitive staining in IHC? Review the different chromogenic detection methods and kits available, including for biotin-based (eg ABC) and polymer methods.
Antibody conjugation kits from the antibody experts. Ready in <20 mins and <1 min hands-on-time. Find the right kit to make your own fluorescent antibody conjugate.
Comprehensive guide to Human CD antigens.
Accurately phenotype human effector T cell subsets with the best markers.
T cells play a central role in cell-mediated immunity and their study can help to uncover the mechanisms of many diseases including cancer.
We've added to our range of best-in-class IHC optimized antibodies to bring you access to more highly validated antibodies against immuno-oncology targets.
Find the antibodies and assay kits you need to unlock the power of immuno-oncology. Includes products for PD-L1, PD-1, CTLA4 and CXCR4.
Learn why our anti-GFP (ab290) antibody is the most highly-cited anti-GFP option available.